X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4192) 4192
Publication (222) 222
Newsletter (99) 99
Book Review (78) 78
Book Chapter (20) 20
Dissertation (17) 17
Magazine Article (11) 11
Newspaper Article (9) 9
Conference Proceeding (3) 3
Reference (3) 3
Trade Publication Article (3) 3
Book / eBook (2) 2
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2144) 2144
male (1421) 1421
hypertension (1325) 1325
index medicus (1316) 1316
angiotensin ii receptor blockers (1221) 1221
animals (1067) 1067
female (966) 966
hypertension - drug therapy (857) 857
middle aged (734) 734
pharmacology & pharmacy (694) 694
angiotensin ii type 1 receptor blockers - therapeutic use (663) 663
angiotensin-converting enzyme inhibitors - therapeutic use (640) 640
angiotensin (629) 629
peripheral vascular disease (624) 624
angiotensin ii receptor blocker (612) 612
aged (602) 602
rats (590) 590
antihypertensive agents - therapeutic use (563) 563
blood pressure - drug effects (521) 521
blood-pressure (519) 519
losartan (510) 510
drug therapy (496) 496
renin-angiotensin system (463) 463
research (454) 454
adult (439) 439
angiotensin ii type 1 receptor blockers - pharmacology (432) 432
tetrazoles - therapeutic use (406) 406
drug therapy, combination (402) 402
treatment outcome (400) 400
cardiac & cardiovascular systems (397) 397
risk factors (396) 396
renin-angiotensin system - drug effects (375) 375
blood pressure (372) 372
dosage and administration (371) 371
hypertension - physiopathology (370) 370
angiotensin ii (362) 362
ace inhibitors (358) 358
valsartan (357) 357
angiotensin receptor antagonists (342) 342
care and treatment (303) 303
urology & nephrology (288) 288
heart failure (279) 279
tetrazoles - pharmacology (277) 277
health aspects (276) 276
telmisartan (275) 275
ii receptor antagonist (268) 268
benzimidazoles - therapeutic use (258) 258
mortality (255) 255
prevention (253) 253
angiotensin-converting enzyme inhibitors (243) 243
hypertension - complications (239) 239
medicine, general & internal (238) 238
angiotensin-converting enzyme inhibitors - pharmacology (237) 237
medicine & public health (236) 236
analysis (229) 229
angiotensin-ii (226) 226
renin-angiotensin system - physiology (224) 224
diabetes (222) 222
antihypertensive agents - pharmacology (221) 221
heart-failure (219) 219
physiological aspects (209) 209
double-blind (207) 207
valine - analogs & derivatives (205) 205
losartan - therapeutic use (203) 203
oxidative stress (203) 203
angiotensin ii type 1 receptor blockers - administration & dosage (202) 202
expression (202) 202
rats, sprague-dawley (202) 202
antihypertensive agents - administration & dosage (201) 201
losartan - pharmacology (201) 201
ii receptor blocker (199) 199
angiotensin receptor antagonists - therapeutic use (196) 196
benzimidazoles - pharmacology (192) 192
internal medicine (189) 189
time factors (182) 182
double-blind method (179) 179
candesartan (177) 177
angiotensin-converting enzyme inhibitor (175) 175
dose-response relationship, drug (175) 175
irbesartan (175) 175
mice (174) 174
converting enzyme-inhibitors (172) 172
proteinuria (172) 172
tetrazoles - administration & dosage (171) 171
antihypertensive agents - adverse effects (170) 170
disease models, animal (170) 170
randomized controlled trials as topic (169) 169
prospective studies (167) 167
medicine, research & experimental (165) 165
angiotensin ii receptor antagonists (160) 160
risk (160) 160
enzymes (159) 159
nephropathy (159) 159
angiotensin ii receptor antagonist (158) 158
cardiovascular diseases (158) 158
physiology (157) 157
angiotensin ii receptors (155) 155
heart failure - drug therapy (154) 154
calcium channel blockers - therapeutic use (153) 153
clinical trials as topic (153) 153
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3869) 3869
Japanese (272) 272
Chinese (108) 108
Russian (38) 38
Spanish (19) 19
German (15) 15
French (10) 10
Italian (5) 5
Korean (4) 4
Slovak (3) 3
Polish (2) 2
Czech (1) 1
Portuguese (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Hypertension, ISSN 0194-911X, 06/2012, Volume 59, Issue 6, pp. 1132 - 1138
Journal Article
by Park, DH and Yun, GY and Eun, HS and Joo, JS and Kim, JS and Kang, SH and Moon, HS and Lee, ES and Lee, BS and Kim, KH and Kim, SH
MEDICINE, ISSN 0025-7974, 11/2017, Volume 96, Issue 47, p. e8905
Rationale: Angiotensin II receptor blockers (ARBs) are widely used for patients with hypertension, and fimasartan is a recently approved ARBs. Fimasartan can... 
drug-induced liver injury | MEDICINE, GENERAL & INTERNAL | LOSARTAN | SAFETY | CANDESARTAN | IRBESARTAN | fimasartan | HEPATIC-INJURY | angiotensin II receptor blockers | INDUCED HEPATOTOXICITY
Journal Article
Journal Article
Circulation: Cardiovascular Quality and Outcomes, ISSN 1941-7713, 10/2017, Volume 10, Issue 10
Background-Once the patent of a brand-name drug expires, generic drugs are commercialized, and substitution from brand-name to generics may occur. Generic drug... 
generic drugs | adverse events complications | brand-name drugs | angiotensin II receptor blockers | pharmacoepidemiology | POTENTIAL SAVINGS | CARDIAC & CARDIOVASCULAR SYSTEMS | METAANALYSIS | THERAPEUTIC SUBSTITUTION | CLINICAL CONSEQUENCES | EQUIVALENCE | ATRIAL-FIBRILLATION | WARFARIN | CARDIOVASCULAR-DISEASE | SURVEILLANCE | Drug Costs | Humans | Patient Admission | Tetrazoles - economics | Drugs, Generic - economics | Hypertension - drug therapy | Benzimidazoles - economics | Angiotensin Receptor Antagonists - economics | Drugs, Generic - therapeutic use | Time Factors | Valsartan - therapeutic use | Patient Safety | Hypertension - mortality | Retrospective Studies | Benzimidazoles - adverse effects | Hypertension - diagnosis | Drug Substitution - adverse effects | Hypertension - economics | Antihypertensive Agents - economics | Benzimidazoles - therapeutic use | Databases, Factual | Losartan - economics | Emergency Service, Hospital | Quebec - epidemiology | Drug Substitution - economics | Risk Factors | Valsartan - adverse effects | Treatment Outcome | Antihypertensive Agents - therapeutic use | Antihypertensive Agents - adverse effects | Drugs, Generic - adverse effects | Losartan - therapeutic use | Losartan - adverse effects | Tetrazoles - therapeutic use | Referral and Consultation | Tetrazoles - adverse effects | Valsartan - economics | Angiotensin Receptor Antagonists - therapeutic use | Population Surveillance | Angiotensin Receptor Antagonists - adverse effects | Therapeutic Equivalency
Journal Article
Journal Article
Journal Article
Kidney International, ISSN 0085-2538, 01/2013, Volume 83, Issue 1, pp. 167 - 176
The OSCAR study was a multicenter, prospective randomized open-label blinded end-point study of 1164 Japanese elderly hypertensive patients comparing the... 
cardiovascular disease | combination therapy | CKD | hypertension | high-dose ARB | METAANALYSIS | RENAL-FUNCTION | NEPHROPATHY | BLOOD-PRESSURE | HYDROCHLOROTHIAZIDE | SERUM CREATININE | GLOMERULAR-FILTRATION-RATE | THERAPY | UROLOGY & NEPHROLOGY | OUTCOMES | PARTICIPANTS | Prospective Studies | Cardiovascular Diseases - prevention & control | Humans | Angiotensin Receptor Antagonists - pharmacology | Calcium Channel Blockers - therapeutic use | Hypertension - drug therapy | Male | Renal Insufficiency, Chronic - complications | Glomerular Filtration Rate - physiology | Incidence | Dose-Response Relationship, Drug | Renal Insufficiency, Chronic - epidemiology | Glomerular Filtration Rate - drug effects | Aged, 80 and over | Female | Blood Pressure - drug effects | Blood Pressure - physiology | Hypertension - epidemiology | Drug Therapy, Combination | Cardiovascular Diseases - etiology | Comorbidity | Japan | Treatment Outcome | Calcium Channel Blockers - pharmacology | Renal Insufficiency, Chronic - physiopathology | Hypertension - complications | Aged | Angiotensin Receptor Antagonists - therapeutic use | Angiotensin II receptors | Calcium channels | Epidermal growth factor receptors | Risk groups | Antihypertensives | Blood pressure | Kidney diseases | Heart diseases | Geriatrics | Glomerular filtration rate | Clinical Trial
Journal Article